See more : International Digital Holding Inc. (IDIG) Income Statement Analysis – Financial Results
Complete financial analysis of Meihua International Medical Technologies Co., Ltd. (MHUA) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Meihua International Medical Technologies Co., Ltd., a leading company in the Medical – Instruments & Supplies industry within the Healthcare sector.
You may be interested
- Floridienne S.A. (FLOB.BR) Income Statement Analysis – Financial Results
- Sky Petroleum, Inc. (SKPI) Income Statement Analysis – Financial Results
- Hirose Tusyo Inc. (7185.T) Income Statement Analysis – Financial Results
- Ncondezi Energy Limited (NCCL.L) Income Statement Analysis – Financial Results
- Greene County Bancorp, Inc. (GCBC) Income Statement Analysis – Financial Results
Meihua International Medical Technologies Co., Ltd. (MHUA)
About Meihua International Medical Technologies Co., Ltd.
Meihua International Medical Technologies Co., Ltd. engages in the manufacture and marketing of medical consumables in the People's Republic of China. It offers class I, II, and III disposable medical devices. The company's products include non-bottled products, such as brushes and ID bracelets; and polyethylene bottled products, such as eye drop and tablet bottles. It also distributes disposable medical devices sourced from other manufacturers to customers in China. The company serves hospitals, pharmacies, medical institutions, and medical equipment companies. It also exports its products to Europe, North America, South America, Asia, Africa, and Oceania. The company was founded in 1991 and is based in Yangzhou, the People's Republic of China. Meihua International Medical Technologies Co., Ltd. operates as a subsidiary of Bright Accomplish Limited.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 97.10M | 103.35M | 104.04M | 89.06M | 79.63M | 75.71M |
| Cost of Revenue | 64.00M | 65.25M | 64.23M | 51.90M | 47.42M | 43.82M |
| Gross Profit | 33.10M | 38.10M | 39.81M | 37.16M | 32.21M | 31.89M |
| Gross Profit Ratio | 34.08% | 36.86% | 38.26% | 41.72% | 40.45% | 42.12% |
| Research & Development | 2.75M | 2.96M | 2.73M | 2.49M | 3.21M | 2.87M |
| General & Administrative | 7.82M | 13.04M | 5.32M | 3.71M | 3.28M | 4.16M |
| Selling & Marketing | 7.30M | 5.64M | 6.46M | 6.62M | 5.41M | 5.67M |
| SG&A | 15.67M | 18.68M | 11.78M | 10.34M | 8.68M | 9.85M |
| Other Expenses | 1.00 | 898.66K | -50.44K | 864.79K | 926.20K | 0.00 |
| Operating Expenses | 18.42M | 22.54M | 14.50M | 13.69M | 12.82M | 13.10M |
| Cost & Expenses | 82.42M | 87.79M | 78.74M | 65.59M | 60.24M | 56.92M |
| Interest Income | 873.44K | 63.73K | 23.86K | 36.58K | 48.84K | 77.42K |
| Interest Expense | 250.78K | 194.67K | 180.74K | 137.16K | 97.79K | 0.00 |
| Depreciation & Amortization | 470.99K | 563.46K | 622.47K | 523.43K | 509.22K | 567.77K |
| EBITDA | 15.77M | 16.12M | 26.88M | 23.99M | 19.90M | 19.74M |
| EBITDA Ratio | 16.24% | 15.61% | 24.89% | 26.95% | 25.05% | 26.08% |
| Operating Income | 14.67M | 15.57M | 25.30M | 23.47M | 19.39M | 19.18M |
| Operating Income Ratio | 15.11% | 15.06% | 24.32% | 26.35% | 24.35% | 25.33% |
| Total Other Income/Expenses | 373.84K | 89.29K | -32.91K | 267.35K | -137.69K | -465.98K |
| Income Before Tax | 15.05M | 10.89M | 25.27M | 23.73M | 19.25M | 18.71M |
| Income Before Tax Ratio | 15.50% | 10.54% | 24.29% | 26.65% | 24.18% | 24.72% |
| Income Tax Expense | 3.46M | 4.71M | 5.28M | 4.69M | 3.82M | 3.23M |
| Net Income | 11.63M | 6.24M | 20.95M | 19.05M | 15.43M | 15.48M |
| Net Income Ratio | 11.97% | 6.04% | 20.14% | 21.38% | 19.38% | 20.44% |
| EPS | 0.49 | 0.27 | 0.89 | 0.79 | 0.64 | 0.77 |
| EPS Diluted | 0.49 | 0.27 | 0.89 | 0.79 | 0.64 | 0.77 |
| Weighted Avg Shares Out | 23.94M | 23.41M | 23.60M | 24.14M | 24.14M | 20.00M |
| Weighted Avg Shares Out (Dil) | 23.94M | 23.41M | 23.60M | 24.14M | 24.14M | 20.00M |
Meihua International Medical Technologies Co., Ltd Regains Compliance with Nasdaq Minimum Bid Price Requirement
YANGZHOU, China , Oct. 7, 2024 /PRNewswire/ -- Meihua International Medical Technologies Co., Ltd. ("MHUA" or the "Company") (Nasdaq: MHUA), a reputable manufacturer and provider of Class I, II, and III disposable medical devices with operating subsidiaries in China, today...
Meihua International Medical Technologies Co., Limited Reports Unaudited 2024 First Half Financial Results
YANGZHOU, China , Sept. 20, 2024 /PRNewswire/ -- Meihua International Medical Technologies Co., Ltd.
Meihua International Medical Technologies Co., Ltd. to Present at LIVE!
YANGZHOU, China , Aug. 26, 2024 /PRNewswire/ -- Meihua International Medical Technologies Co., Ltd. ("MHUA" or the "Company") (Nasdaq: MHUA), a reputable manufacturer and provider of Class I, II, and III disposable medical devices with operating subsidiaries in China, today announced...
Meihua International Medical Technologies Facilitates World's Second* 5G Remote Robot-Assisted Lobectomy
YANGZHOU, China , July 31, 2024 /PRNewswire/ -- Meihua International Medical Technologies Co., Ltd. ("MHUA" or the "Company") (Nasdaq: MHUA), a reputable manufacturer and provider of Class I, II and III disposable medical devices with operating subsidiaries in China, today...
Meihua International Medical Technologies Co., Ltd. Announces Share Repurchase Program of Up to $3 million
YANGZHOU, China, July 1, 2024 /PRNewswire/ -- Meihua International Medical Technologies Co., Ltd. ("MHUA" or the "Company") (Nasdaq: MHUA), a reputable manufacturer and provider of Class I, II and III disposable medical devices with operating subsidiaries in China, announced today...
Meihua International Medical Technologies Co., Ltd. to Present at the Sidoti Small Cap Conference and Update Investors at the Emerging Growth Conference on June 13, 2024
YANGZHOU, China , June 11, 2024 /PRNewswire/ -- Meihua International Medical Technologies Co., Ltd. ("MHUA" or the "Company") (Nasdaq: MHUA), a reputable manufacturer and provider of Class I, II, and III disposable medical devices with operating subsidiaries in China, is...
Meihua International Medical Technologies Co., Ltd. to Present at the Emerging Growth Conference on May 9, 2024
Meihua International Medical Technologies Co., Ltd. invites individual and institutional investors as well as advisors and analysts, to attend its real-time, interactive presentation at the Emerging Growth Conference.
Meihua International Medical Technologies Co., Ltd. Reports 2023 Financial Year Results
YANGZHOU, China , April 24, 2024 /PRNewswire/ -- Meihua International Medical Technologies Co., Ltd. ("MHUA" or the "Company") (Nasdaq: MHUA), a reputable manufacturer and provider of Class I, II, and III disposable medical devices with operating subsidiaries in China, today...
Meihua International Medical Technologies Co., Ltd. Announces Closing of Initial $6 Million Tranche of Potential $50.5 Million Maximum Offering
YANGZHOU, China , Jan. 2, 2024 /PRNewswire/ -- Meihua International Medical Technologies Co., Ltd. ("MHUA" or the "Company") (NASDAQ: MHUA), a reputable manufacturer and provider of Class I, II and III disposable medical devices with operating subsidiaries in China, today...
Meihua International Medical Technologies Co., Ltd. Announces Initial $6 Million Tranche of Potential $50.5 Million Maximum Offering
YANGZHOU, China , Dec. 28, 2023 /PRNewswire/ -- Meihua International Medical Technologies Co., Ltd. ("MHUA" or the "Company") (NASDAQ: MHUA), a reputable manufacturer and provider of Class I, II and III disposable medical devices with operating subsidiaries in China, announced...
Source: https://incomestatements.info
Category: Stock Reports